Search
for
Sort by
Research 30 of 38
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- Immune checkpoint inhibitor‐related alopecia: Insight into the pathophysiology utilizing non‐invasive diagnostic techniques
- Hair disorders in patients with cancer
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Cancer Treatments and Alopecia: A Systematic Review
- Management of Toxicities of Targeted Therapies
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature
- Adrenal myelolipoma: A rare entity
- Cutaneous manifestations associated with immune checkpoint inhibitors
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Alopecia Areata: Current Treatments and New Directions
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Poster Presentations
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis